Wassim McHayleh, MD | An Investigational Breast Cancer Drug Has Been a Game Changer for a Central FL Patient

Dr. McHayleh was recently featured in an article by Florida trend as a part of the Breast Cancer Month publication where he was able to discuss his clinical trial Tropion. In the article it discusses how one of the participants was declared cancer-free after roughly 5 months of the trail. Check out the article to learn more about this great work. Read More Recent News News Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus. June 10, 2025 Under the leadership of principal investigator Michael Seidman, MD, AdventHealth Research Institute is participating in the multi-site Clinical Trial of Etanercept (TNF-alpha Blocker) for Treatment of... Read Article about "Dr. Michael Seidman is Participating in a New Study to Test Treatment for Blast-induced Tinnitus." News AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes June 05, 2025 Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at... Read Article about "AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes " News Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health June 04, 2025 Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health Read Article about "Dr. Kirk Erickson Joins the NavNeuro Podcast to Discuss the Connection Between Physical Activity and Brain Health" View More Articles